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ABSTRACT: Lysyl oxidases (LOXs) play a central role in extracellular matrix remodeling during development and
tumor growth and fibrosis through cross-linking of collagens and elastin. We have limited knowledge of the
structure and substrate specificity of these secreted enzymes. LOXs share a conserved C-terminal catalytic domain
but differ in their N-terminal region, which is composed of 4 repeats of scavenger receptor cysteine-rich (SRCR)
domains in LOX-like (LOXL) 2. We investigated by X-ray scattering and electron microscopy the low-resolution
structure of the full-length enzyme and the structure of a shorter form lacking the catalytic domain. Our data
demonstrate that LOXL2 has a rod-like structure with a stalk composed of the SRCR domains and the catalytic
domain at its tip. We detected direct interaction between LOXL2 and tropoelastin (TE) and also LOXL2-mediated
deamination of TE. Using proteomics, we identified several allysines together with cross-linked TE peptides. The
elastin-like material generated was resistant to trypsin proteolysis and displayed mechanical properties similar to
mature elastin. Finally, we detected the codistribution of LOXL2 and elastin in the vascular wall. Altogether, these
data suggest that LOXL2 could participate in elastogenesis in vivo and could be used as ameans of cross-linking TE
in vitro for biomimetic and cell-compatible tissue engineering purposes.—Schmelzer, C. E.H.,Heinz,A., Troilo,H.,
Lockhart-Cairns, M.-P., Jowitt, T. A., Marchand, M. F., Bidault, L., Bignon, M., Hedtke, T., Barret, A., McConnell,
J. C., Sherratt, M. J., Germain, S., Hulmes, D. J. S., Baldock, C., Muller, L. Lysyl oxidase–like 2 (LOXL2)–mediated
cross-linking of tropoelastin. FASEB J. 33, 5468–5481 (2019). www.fasebj.org
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Extracellular matrix (ECM) remodeling plays a central
role in morphogenesis and development as well as in tis-
sue responses to pathologies, including fibrosis and is-
chemic vascular diseases. The ECM provides cells with
mechanical and chemical cues, and its remodeling in-
volves both proteolysis of pre-existing ECMand synthesis
of a new microenvironment, as regulated by expression
and activity of enzymes responsible for post-translational
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modifications. Acquiring a better understanding of these
modificationsanddevelopingnewtools toaddress themis
also an issue in the context of tissue engineering because
natural polymers are gaining interest as biomaterials for
stem cell–based therapeutic approaches. Biomimicking
approaches using recombinant enzymes involved in ECM
remodeling are thus primary candidates for the pro-
duction of cell-encapsulating biomaterials.
Cross-linking of ECM proteins is a major step in
microenvironment remodeling because this modulates
both tensile strength and elastic properties depending on
the substrate (i.e., collagens and elastin, respectively).
These post-translational modifications are performed by
transglutaminases and lysyl oxidases (LOXs), whose
specific substrates remain to be determined. LOXs share
a conserved C-terminal amine oxidase catalytic domain
consisting of a copper-binding motif and a lysine tyro-
sylquinone cofactor (reviewed in refs. 1–3). They catalyze
the oxidative deamination of the e-amino group of lysines
and hydroxylysines in collagens and elastin. The re-
sultant highly reactive aldehydes eventually condense
with other oxidized groups or unaltered lysine residues
to form a variety of cross-links. The LOX family is
composed of 2 subgroups containing LOX and LOX-like
(LOXL) 1 and LOXL2–4, respectively. The C-terminal
catalytic domains of LOX and LOXL1 share a homology
of 88%, and those of LOXL2–4 share a homology of
84–86%, whereas the homology between these 2 groups
is only 64–68% [reviewed by Moon et al. (2)]. The N-
terminal domains of LOX and LOXL1 are shorter than
the catalytic domain and act as prodomains, regulating
activation and activity of the catalytic domain, whereas
the N-terminal region of LOXL2–4 consists of 4 adjacent
scavenger receptor cysteine-rich (SRCR) domains,which
make up two-thirds of the full-length protein. Their
functions remain tobedetermined. Indeed,processingof the
N-terminaldomainofLOXL2betweenSRCRdomains2and
3 was recently described as having no impact on enzyme
activation, per se (4). Although the specific substrates of each
memberof the familyarenotyetknown,gene inactivationof
LOX and LOXL1 has provided interesting clues concerning
the natural substrates of these enzymes and the tissues
where they are modified (5–8).
LOXL2 was proposed to cross-link collagen IV (9, 10),
andwe have demonstrated the regulation of angiogenesis
by LOXL2 (9). LOXL2 also regulates chondrocyte differ-
entiation, suggesting that it is a multifunctional enzyme
(11). There is in addition an extensive literature concerning
its involvement in the maintenance of pathologic envi-
ronments (12), including fibrosis, tumor progression,
and metastasis dissemination, that suggested that
LOXL2 cross-links fibrillar collagens. LOXL2 is indeed
considered an important therapeutic target in heart failure
and fibrosis (13). We, however, still lack investigations of
LOXL2-mediated oxidation of other collagens and elastin
[reviewed by Moon et al. (2)]. The first patients carrying
LOXL2 mutations were recently identified as suffering
frommiddermalelastolysis (14), raising thepossibility that
LOXL2 could participate in elastin cross-linking. In the
present study,we first determined the nanoscale structure
of both full-length LOXL2 (FL-LOXL2) and a catalytic
domain–deleted form that only comprises the 4 SRCR
domains (SRCR14). We then investigated interactions
with tropoelastin (TE) and the ability of LOXL2 to oxidize
and cross-link TE. We measured the level of LOXL2-
generated desmosine and found that cross-linking of
coacervated TE affects both its stiffness and resistance to
proteolytic degradation, thus suggesting the involvement
of LOXL2 in elastin biosynthesis and making it a promis-
ing tool for the fabrication of elastin-based biomaterials.
MATERIALS AND METHODS
Protein purification
cDNA encoding human FL-LOXL2 or a truncated form consist-
ing of SRCR14 was inserted into pcDNA3.1-myc-His at the Hin-
dIII and XbaI restriction sites. PCR fragments were generated
using the following primers: 59-AAGCTTATGGAGAGG-
CCTCTG-39 and 59-TCTAGACTGCGGGGACAGCTG-39 for
FL-LOXL2 and 59-TCTAGAGGTTTCTGAGCAGGC-39 for
SRCR14. Dihydrofolate reductase (DHFR)–deficient Chinese
hamster ovary (CHO) cells were cotransfectedwith the dhfr gene
and constructs encoding FL-LOXL2 or SRCR14 using Lipofect-
amine 2000 according to the manufacturer’s recommendations
(ThermoFisher Scientific,Waltham,MA,USA).High-expression
clones were selected by serial subcloning in the presence of
increasing concentrations of methotrexate (MilliporeSigma,
Burlington, MA, USA). Transfected CHO cells were cultured in
Opti-MEM (Thermo Fisher Scientific) for protein production.
PurificationwasperformedonHisTrap columns (GEHealthcare,
Waukesha, WI, USA). Protein was eluted at 200 mM imidazole,
and buffer was exchanged for 50 mM Na phosphate buffer
(pH 7.4) containing 150 mMNaCl by gel filtration.
Recombinant human FLAG-tagged bone morphogenetic
protein-1 (BMP-1) (in 20 mM Na-HEPES, 0.5 M NaCl, 2.5 mM
CaCl2, and 0.1% n-octylglucoside, pH 7.4) and His-tagged pro-
collagen C-proteinase enhancer 1 (PCPE-1) (in 20 mM Na-
HEPES, 0.5MNaCl, and 5mMCaCl2, pH 7.4) were produced in
293- Epstein–Barr nuclear antigen (EBNA) cells as described in
Blanc et al. (15). The control substrate CPIII-Long (in 20 mM
HEPES, 0.5 M NaCl, and 5 mMCaCl2, pH 7.4) was produced in
293-EBNA cells as described in Bourhis et al. (16).
Human TE, isoform 2 was produced in an Escherichia coli ex-
pression system based on refs. 17 and 18 with somemodifications.
In brief, bio wet mass was heated in a microwave to inactivate
intrinsic proteases. Cell disintegrationwas carried out using a high-
pressurehomogenizer.After centrifugation, TEwas extracted twice
from the pellet using an acetone and buffermixture. The combined
extracts were evaporated and concentrated by partial removal of
water, and the turbid suspension was filtered. The precipitated TE
on the filter membrane was solubilized by the addition of buffer
and decolorized by the addition of charcoal. After filtering off the
charcoal, the TE solutionwasdialyzed twice against distilledwater.
In the last step, pure TE was isolated by freeze drying.
Bovine aortic elastin and human aortic elastin were isolated
from aortic tissue as previously described in Schmelzer et al. (19).
Analytical-grade Tris and formic acid were purchased from
Merck (Darmstadt, Germany). HPLC-grade acetonitrile was
obtained fromVWR International (West Chester, PA, USA), and
TFA was obtained fromMilliporeSigma.
Proteolysis experiments
Proteolytic processing of LOXL2 produced by CHO cells was
analyzed in overnight secretion medium prepared in the pres-
ence of different serine protease inhibitors [aprotinin, leupeptin,
and 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride].
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Proteins were solubilized with Laemmli buffer, and LOXL2 was
detected by Western blotting using anti-LOXL2 from Abnova
(Taipei City, Taiwan). To test for possible cleavage of LOXL2 by
BMP-1, 100 ml of purified FL-LOXL2 was first dialyzed exten-
sively against assay buffer (50 mMNa-HEPES, pH 7.4; 150 mM
NaCl; 5 mM CaCl2) at 4°C overnight. Reactions were set up
containing 2.8 mg/ml (20 nM) BMP-1, 25 mg/ml (150 nM) FL-
LOXL2, or 48 mg/ml (200 nM) CPIII-Long [used as a positive
control (16)] with or without 200 nM PCPE-1, with Brij 35
(ThermoFisher Scientific) added to a final concentration of 0.02%
(w/v) in low-binding Eppendorf tubes (Eppendorf, Hamburg,
Germany) for 2 h at 37°C. Reactions were stopped by transfer
to ice and addition of EDTA and 53 Laemmli sample to a final
concentration of 50 mM EDTA, followed by heating to 100°C
for 3 min. Samples were analyzed by SDS-PAGE using 4–20%
gradient gels (Bio-Rad, Hercules, CA, USA) and staining with
Coomassie Blue (MilliporeSigma).
Human TE, cross-linked TE (cTE), and aortic elastin were
weighed anddissolved or dispersed at a concentration of 5mg/ml
in 50 mM Tris-HCl, pH 7.5. Digestions with cathepsin G (CG;
Elastin Products Company, Owensville,MO,USA), trypsin (Serva
Electrophoresis, Heidelberg, Germany), and porcine pancreatic
elastase (PE; Elastin Products Company) were carried out at 37°C
for 24 h at enzyme:substrate ratios of 1:100 (w/w), 1:100 (w/w),
and 1:50 (w/w), respectively. All digestions were stopped by addi-
tion of TFA to a final concentration of 0.5% (v/v), and then samples
were stored at226°C until mass spectrometry (MS) analysis.
Multiangle light scattering, analytical
ultracentrifugation, and circular dichroism
Samples (0.5 ml at ;0.5 mg/ml) in 50 mM Na phosphate and
500 mMNaCl, pH 7.4 were injected onto a gel filtration column
(Superdex 200 for FL-LOXL2 or Superdex 75 for SRCR14; GE
Healthcare) at 0.75 ml/min. For multiangle light scattering,
samples were passed through a Dawn Heleos II 18-angle laser
photometer (Wyatt Technology, Santa Barbara, CA, USA). This
was coupled to an Optilab rEX refractive index detector (Wyatt
Technology), and data were analyzed using Astra 6 software
(Wyatt Technology). Sedimentation velocity analytical ultracen-
trifugation (AUC)was carried out at 45,000 rpmat 20°Cusing an
XL-A ultracentrifuge with an An-50 Ti 4-Hole Rotor (Beckman
Coulter, Brea, CA, USA). Sedimentation was scanned every 90 s
for 200 scans. Data were analyzed using Sedfit (https://sedfitsed-
phat.nibib.nih.gov/software/default.aspx).
Prior to analysis by circular dichroism (CD), samples of
recombinant LOXL2 and SRCR14 were further purified by gel
filtration using a Superdex 200 10/300 column pre-equilibrated
in 50 mM Na phosphate and 150 mM NaCl, pH 7.4. Peak frac-
tions were analyzed by SDS-PAGE using 4–20% gradient gels
in nonreducing conditions. Far UV (192–260 nm) CD measure-
ments were carried out using thermostated 0.2-mm path length
quartz cells in an Applied Photophysics (Leatherhead, United
Kingdom) Chirascan instrument [Protein Science Facility,
Structure Fe´de´rative de Recherche (SFR) BiosciencesUnite´ Mixte
de Service (UMS) 3444/Unite´ de Service (US) 8, Lyon, France].
Proteins (;200mg/ml)were analyzed at 25°C in the samebuffer.
Spectra were measured in duplicate using a wavelength in-
crement of 1 nm, an integration time of 8 s, and a bandpass of
1 nm. Protein concentrations were determined by Nanodrop
(Thermo Fisher Scientific). Observed ellipticities were converted
to mean residue molar ellipticities, taking into account mean
residue weight, cell path length, and protein concentration.
Small-angle X-ray scattering
For small-angle X-ray scattering (SAXS), samples of FL-LOXL2
and SRCR14 in the concentration range 3–6 mg/ml were
prepared in 50 mM Na phosphate and 0.15 M NaCl, pH 7.4.
Before loading, samples were centrifuged for 10 min at 12,000 g,
and the supernatants were collected. Initial data collection was
carried out on beamline B21 at Diamond Light Source (Didcot,
United Kingdom) using the in-house BioSAXS robot. This
revealed the presence of small amounts of aggregatedmaterial in
both specimens at these high concentrations. To completely
eliminate aggregates, further experimentswere carried out at the
European Synchrotron Radiation Facility (ESRF; Grenoble,
France) on beamline B29 using in-line size-exclusion chroma-
tography (Superdex 200 Increase 3.2/300). Prior to injection,
samples were concentrated to;6 mg/ml using Vivaspin 500 ml
10-kDa concentrators (Vivaproducts, Littleton,MA,USA). SAXS
data were collected throughout elution from the column at 1-s
intervals, and the radius of gyration (Rg) was automatically cal-
culated for each scan. Scans throughout the elution peak with
constant Rg values were then pooled and used for subsequent
structuremodeling. Datawere processed using the PRIMUS (20)
andGNOM (21) programs. Low-resolution structures were then
modeled using the programs DAMMIF (22) and MONSA (23).
Rigid-body modeling was performed to the SAXS data with
CORAL (23) using homology models of the first and second
SRCRdomains and the structures of SRCRdomains 3, 4, and the
catalytic domain (24).
Electron microscopy single-particle reconstruction
FL-LOXL2 (10 mg/ml) was first absorbed onto glow-discharged
carbon-coated grids and stainedwith 4%uranyl acetate (pH4.7).
Images were recorded at 323,000 on a Tecnai Biotwin (Field
Electron and Ion Company; Thermo Fisher Scientific) at 120 kV
with an Orius CCD camera (Gatan, Pleasanton, CA) with a 1-s
exposure at 0.5–1.5 mm defocus range at 2.8 A˚/pixel. Using
EMAN2 (25), 10,000 particles were picked using a combination
of manual and semiautomated picking. The contrast transfer
function was corrected, and the dataset was subjected to
2-dimensional classification. These classeswereused togenerate
an initial 3-dimensional (3D)model to seed 6 rounds of iterative
refinement to produce a self-consistent 3D structure. Data were
split into odd and even numbers, and each dataset was refined
independently to produce a resolution curve for each stage of
refinement.With a Fourier shell correlation cutoff value of 0.143,
the resolution estimate was 22 A˚. Modeling was performed us-
ingUniversity ofCalifornia–SanFrancisco (UCSF)Chimera (26).
Surface plasmon resonance
Protein-protein interactions were measured with a ProteOn
XPR36 (Bio-Rad) in 10 mM Na-HEPES, 150 mM NaCl, 2 mM
CaCl2, and 0.05% Tween 20, pH 7.4 (running buffer) at 25°C.
Proteinswere immobilized on aGLC chip (Bio-Rad) via standard
amine coupling with 1-Ethyl-3-(3-dimethylaminopropyl)car-
bodiimide (EDS)/N-hydroxysulfosuccinimide (s-NHS) using
10 mg/ml LOXL2 diluted in 100 mM acetate buffer, pH 5.0 at
100 ml/min for 60 s. Free reactive N-hydroxysulfosuccinimide
(NHS) esters were blocked using ethanolamine. A reference
lane was activated and blockedwith ethanolamine but with no
LOXL2 added. The chip was rotated by 90°, and analytes were
flowed over the LOXL2 and reference sensors in sequential
lanes using a serial 1:1 dilution from 830 nMTE at a flow rate of
100ml for 120 swith adissociation timeof 300 s. Regeneration of
the LOXL2 was achieved using a 30-s pulse of 50 mM NaOH.
LOX activity and cross-linking experiments
LOXL2 activitywasmeasured using the AmplexUltraRed assay
(Thermo Fisher Scientific) as previously described in Trackman
and Bais (3). For this, 4 mg LOXL2 was assayed in 50 mM Na
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borate, pH8.2 inthepresenceof10mMcadaverin(MilliporeSigma),
10 mMAmplex UltraRed, and 1 U/ml horseradish peroxidase
(MilliporeSigma). LOXL2 activity was also measured using
1.25 mM laminin or 1.65 mM TE. Resorufin fluorescence was
measured at 37°C for 60 min using an EnVision Xcite multi-
mode plate reader (PerkinElmer,Waltham,MA, USA) at lex =
535 nm and lem = 610 nm. The amount of H2O2 released by
LOXL2 was determined using a standard curve of hydrogen
peroxide. b-Aminopropionitrile (b-APN) (500 mM) was added
to the reaction mixture in some experiments. Measurements
were performed in triplicate, and a representative experiment
is shown.
TE was dissolved in 50 mM Na borate buffer, pH 8.0 at a
concentration of 10 mg/ml, then incubated at 50°C for 15 min
to induce coacervation. LOXL2was then added at an enzyme:
substrate ratio of 1:500 (w/w), and the mixture of enzyme
and substrate was incubated at 50°C for 24 h. The precipitated
insoluble cTE that had formed was washed with a solution
of water and ethanol (1:1, v/v), dried in a SpeedVac (Thermo
Fisher Scientific), and stored at 226°C prior to further
analysis.
Mass spectrometric analysis and
peptide identification
Trypsin digests were analyzed using an Ultimate 3000
RSLCnano System (Thermo Fisher Scientific) coupled to a Q-
Tof II Mass Spectrometer (Waters, Milford, MA, USA) as
previously described in Heinz et al. (27). CG and PE digests
were separated on an Ultimate 3000 RSLCnano System
coupled to an Orbitrap Fusion Tribrid mass spectrometer
(Thermo Fisher Scientific) equipped with a Nanospray Flex
Ion Source (Thermo Fisher Scientific). Peptide mixtures were
loaded on the trap column (Acclaim PepMap RP-C18, 300
mm 3 5 mm, 5 mm, 100 A˚; Thermo Fisher Scientific) and
washed with water containing 0.1% TFA for 15 min at the
rate of 30 mL/min before the peptides were separated on the
separation column (Acclaim PepMap RP-C18, 75 mm 3
250 mm, 2 mm, 100 A˚) at a flow rate of 300 nl/min using
gradients from1 to 35% solvent B for 90min and 35–85%B for
5min followed by 85% B for 5min. Solvent B was acetonitrile
containing 0.1% formic acid, and solvent A was water con-
taining 0.1% formic acid. Data were acquired using the data-
dependent tandem MS (MS/MS) mode. Each high-resolution
full scan in the Orbitrap (m/z 300–1500, R = 120,000) was fol-
lowed by high-resolution product ion scans in the Orbitrap
(higher-energy collisional dissociation mode with 27% normal-
ized collision energy, R = 15,000) within 5 s, starting with the
most intense signal in the full-scan mass spectrum. Dynamic
exclusionwas enabled to allow analysis of less-abundant ions.
Data acquisition was controlled with Xcalibur 3.0.63 (Thermo
Fisher Scientific). The raw data of the PE and CG digests were
refined and analyzed using Peaks 7.5 (Bioinformatics Solu-
tions, Waterloo, ON, Canada), and the human subsection
of the Swiss-Prot database was used for database matching.
The mass error tolerance for precursor and fragment ions
was set to 2.0 ppm and 0.015 Da, respectively. The enzyme
was set to “none,” and oxidation of K residues to peptidyl
a-aminoadipic-s-semialdehyde (allysine) anddeamidation of
Q and N were taken into account as variable modifications.
Intramolecular cross-links were detected either by using the
program StavroX (https://www.stavrox.com) (28) or with Peaks
by applying a database with a modified sequence of human
TE. Briefly, cross-linking motifs were reduced to a single K
residue in the sequence, and themass differences between this
residue and the corresponding intramolecularly cross-linked
motif were included as variable post-translationalmodifications
in a separate search.
Detection and quantification of cross-links
All elastin samples were totally hydrolyzed and further treated
and analyzed as previously described inHeinz et al. (27). In brief,
liquid chromatography (LC)–MS analysis of desmosine and
isodesmosine was carried out using an Agilent 1100 LC system
(Agilent Technologies, Santa Clara, CA, USA) coupled to a
quadrupole ion trapmass spectrometer (Finnigan LCQ; Thermo
Fisher Scientific) with an electrospray interface operated in the
positive ion mode.
Atomic force microscopy
Sampleswere rehydrated indistilledwater and left to adhere to a
charged glass slide overnight at room temperature. They were
then rehydrated in distilled water for micromechanical assess-
ment by atomic force microscopy (AFM) indentation using a
Bioscope Catalyst AFM (Bruker, Billerica, MA, USA) mounted
onto an Eclipse T1 inverted optical microscope (Nikon, Tokyo,
Japan) fittedwith a spherically tipped cantilever (nominal radius
and spring constant of 1 mm and 3 N/m, respectively; Windsor
Scientific, Slough, United Kingdom) running Nanoscope Soft-
ware 8.15 (Bruker). The local reduced modulus was determined
for each of 25 points in a 50-mm 3 50-mm region, indented at a
frequency of 1 Hz with lateral spacing of 2 mm. The approach
force curvewas used to calculate the reducedmodulus using the
Hertzian contact mechanics model and a 70% force fit.
Physicochemical characterization of cTE
Differential scanning calorimetry was carried out to determine
the glass transition temperature (Tg) of cTE and bovine aortic
elastin. Experiments were performed using a differential scan-
ning calorimeter (DSC 200; Netzsch-Gera¨tebau, Selb, Germany).
For this, 3mgofdried sampleswasplaced in aluminumpansand
covered bypierced lids. Sampleswereheated from30 to 250°Cat
20°C/min followed by cooling from 250 to 30°C at the same rate.
This program was repeated twice for each sample. The onset of
the Tg was determined using the DSC 200 software. Swelling
properties of cTE and bovine aortic elastin were determined at 4
and 37°C by immersing samples in water. The samples were
taken out after 2 h and weighed after removal of surface-bound
water. All measurements were carried out in triplicate. The
swelling ratio inmilligramsofwater permilligramof protein (i.e.,
the water absorptivity of samples) was calculated using the fol-
lowing equation:
Swelling ratio ¼ wet weight2dry weight
dry weight
Analysis of LOXL2 expression
For immunohistochemistry, aortas from6-wk-oldC57BL/6mice
were embedded in cryoblock medium (VWR International) on
dry ice. Cryosections were incubated with anti-LOX (Abcam,
Cambridge,MA,USA)oranti-LOXL2(SantaCruzBiotechnology,
Dallas, TX, USA) before fixation with acetone and further pro-
cessing with secondary antibodies coupled to Alexa Fluor fluo-
rochromes (Thermo Fisher Scientific) as previously described in
Bignon et al. (9).
Frozen aortas were pulverized on dry ice before lysis in
25mMTris (pH 7.5), 100mMNaCl, 5mMEDTA, and 1%Triton
X-100 containing Protease Inhibitor Cocktail (MilliporeSigma).
Sampleswere centrifuged for 30min at 15,000 g, andpelletswere
solubilized in Laemmli buffer. Proteins of both lysates were
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separated by SDS-PAGE and electrotransfered to PVDF mem-
branes for immunodetection of LOX, LOXL2 (Abnova), fibro-
nectin (Merck), and actin (Abcam).
RESULTS
Production and preliminary biophysical
characterization of recombinant
human LOXL2
For large-scale production of recombinant humanLOXL2,
we selected eukaryotic CHO cell lines expressing high
levels ofHis-taggedLOXL2according to their resistance to
inhibition of DHFR by methotrexate. When cultured for
more than 4 d at high density in roller bottles, these cells
released LOXL2 as 2 bands on SDS-PAGE of ;100 and
;65 kDa with similar intensities, unless serine protease
inhibitors were included in the medium (Supple-
mental Fig. S1A). Detection of these 2 bands after
Ni–nitrilotriacetic acid affinity enrichment for the
C-terminally His-tagged LOXL2 suggested that SRCR
domains 1 and 2 were released by cleavage of LOXL2
between SRCR domains 2 and 3, as recently proposed in
Lo´pez-Jime´nez et al. (4). Because processing of LOX and
LOXL1byBMP-1 is involved in theirproteolytic activation
(29–31),we investigated in vitrowhetherLOXL2wasalsoa
substrate of this protease. No processing of LOXL2 by
BMP-1was observed, even in the presence of the enhancer
PCPE-1 (Supplemental Fig. S1B). CHO cells transfected
with a plasmid encoding either FL-LOXL2 or a shorter
form lacking the catalytic domain (called SRCR14 because
Figure 1. Characterization of recombinant human FL-LOXL2 and the SRCR14 region. A) Schematic representation of
recombinant FL-LOXL2 and of the catalytic domain truncated form (SRCR14). Black box corresponds to the signal peptide.
Dark gray box corresponds to the catalytic domain, containing the copper binding site (Cu), the lysine tyrosylquinone cofactor
(LTQ), and the cytokine receptor–like domain (CRL, in black box). The C-terminal myc-histidine tag (MH) is in red. B, C)
Puriﬁed recombinant proteins were separated by SDS-PAGE and stained with Coomassie Blue (B) and analyzed by CD (C). D, E)
Purity and MWs were also assessed using multiangle laser light scattering AUC. Multiangle laser light scattering was performed
with a Superdex 200 column for LOXL2 and a Superdex 75 for SRCR14 (D). Ultracentrifugation was analyzed using Sedﬁt2 (E).
dRI, differential refractive index; C(s), sedimentation coefﬁcient distribution; Sapp, apparent sedimentation; deg, degrees;
MRW 5 mean residue weight.
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it encompasses the N-terminal SRCR domains 1 to 4) (Fig.
1A) were thus cultured in serum-free medium containing
5 mM aprotinin. Recombinant proteins were affinity pu-
rified and analyzed by Coomassie Blue staining and CD
(Fig. 1A–C). Both proteins gave typical b-sheet spectra
consistent with the known structure of the SRCR domain
(32). Multiangle light scattering and AUC (Fig. 1D, E and
Table 1) revealed that FL-LOXL2 and SRCR14 had MWs
of 92.66 2.8 kDa (93 kDa predicted) and 63.66 2 kDa (65
kDa predicted), respectively, with hydrodynamic radii
corresponding to very extended structures, as also in-
dicated by dynamic light scattering (unpublished results).
Nanoscale structure of recombinant
human LOXL2
In order todetermine the shape and low-resolution structure
ofLOXL2,weperformedSAXSexperimentsusing in-linegel
filtration at the ESRF. Both SRCR14 and FL-LOXL2 behaved
asmonodisperse particles in solution, as shownby the linear
Guinier plots (Supplemental Fig. S2). Distance distribution
plots, calculated using GNOM, confirmed the rod-like
shapes of both molecules, with the SRCR domains alone
extending over;130 A˚ and the catalytic domain adding an
extra;40 A˚ to the length (Supplemental Fig. S2andTable1).
DAMMIF modeling using the SAXS data allowed de-
terminationof the ab initio shapes of eachprotein (Fig. 2A,B).
Rigid-body modeling of SRCR14 performed using CORAL
was superimposed with the ab initio model and showed
similar structures (Fig. 2B). Superimposition of the SRCR14
ab initiomodel within that of LOXL2 suggested that the cat-
alytic domain projects out at one end of the molecule (Fig.
2C). This was confirmed using MONSA, which allowed
separate modeling of the catalytic domain using scattering
data for FL-LOXL2 and its SRCR14 fragment (Fig. 2D).
The structure of FL-LOXL2 was also investigated by
single-particle analysis using transmission electron mi-
croscopy (EM) after negative staining (Fig. 3A–C). Ap-
proximately 10,000 LOXL2 molecules were selected, and
reference-free class averages were generated for 3D re-
construction to 22-A˚ resolution (Fig. 3D and Table 1). Both
the monomeric nature of LOXL2 and the overall shape of
the protein were confirmed. Indeed, the MONSA-SAXS
model could be fitted within the 3D reconstruction of EM
(Fig. 3E). Altogether, these data suggest that the SRCR
catalytic domains are organized in a string of pearls rather
than as a globular structure. Again, the structure de-
termined indicated that the catalytic domain is exposed at
the tip of a stalk-like structure generated by SRCR14.
TABLE 1. Structural characteristics of LOXL2 and SRCR14: comparison of the Rg, hydrodynamic
radius, frictional ratio, and maximum dimension calculated from MALS, AUC, SAXS, and TEM data
Variable
MALS AUC SAXS TEM
LOXL2 SRCR14 LOXL2 SRCR14 LOXL2 SRCR14 LOXL2
MW (kDa) 92.6 63.6 93
Rh (nm) 5.6 4.35 5.8 4.1 6.6
Rg (nm) 4.35 3.64 4.7
S20,W 5.15 4.18 5.52
f/f0 1.44 1.38
Dmax (nm) 17.1 12.9 17.6
Dmax, maximum dimension; f/f0, frictional ratio; MALS, multiangle light scattering; Rh, hydrody-
namic radius; S20,W, sedimentation coefﬁcient; Rg, radius of gyration; TEM, transmission EM.
Figure 2. Low-resolution structures and model-
ing of LOXL2 and SRCR by SAXS analysis. A)
DAMMIF ab initio models of LOXL2. B) The
SRCR DAMMIF ab initio model is superimposed
with the rigid-body model of SRCR14 colored
from blue to red. C) The ab initio model of the
SRCR region (blue) inside the ab initio model of
LOXL2 (mesh). D) MONSA model of LOXL2
with the catalytic domain shown as a solid red
density and the SRCR domains shown in blue,
into which the rigid-body model of the SRCR
domains is docked (shown colored from blue to
red). Scale bar, 5 nm.
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A crystal structure of a glycosylation-deficient mutant
of LOXL2 lacking the 2 N-terminal SRCR domains was
recently described in Zhang et al. (24). Comparison with
our SAXS and EM data suggested a difference in confor-
mation between full-length and truncated LOXL2 (Fig.
4A). Whereas we found using FL-LOXL2 that the SRCR
domains project linearly away from the catalytic domain,
the crystal structure of Zhang et al. (24) indicates that the
SRCR domain 3 folds back on the catalytic domain. The
presenceof large linkers (9–33 residues) between theSRCR
domains adds flexibility to the organization of these do-
mains. Indeed, the best-fittingmodels to the SAXSandEM
data were obtained when SRCR domains 1–3 were con-
sidered freely linked domains, with only SRCR4 con-
nected rigidly to the catalytic domain (Fig. 4B, C).
LOXL2-mediated cross-linking of TE
Wethen investigated the interactionsbetweenLOXL2and
the potential substrate TE. Surface plasmon resonance
Figure 3. Structural analysis of LOXL2 by single-particle EM and image reconstruction. A) Raw image of LOXL2 collected at
323,000, 2.8 A˚/pixel. B) Selected class averages of LOXL2. A total of 32 classes were generated from ;10,000 particles selected
from 150 micrographs. C) Corresponding projections from the 3D reconstruction generated using EMAN2. Box size is 36 nm
(B, C). D) LOXL2 3D reconstruction shown in 2 orientations. E) MONSA-SAXS model (catalytic domain shown in red and SRCR
region in blue) ﬁtted within the EM model (mesh). Two orientations are shown. Scale bar, 5 nm (D, E).
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experiments were performed using immobilized recombi-
nant FL-LOXL2 with TE as the analyte in the mobile phase
(Fig. 5). We determined a dissociation constant of 146 nM
for FL-LOXL2. We thus investigated TE oxidation by
FL-LOXL2. LOXL2 activity (7.7 pM/min/mg) was first
measured using cadaverin as a substrate, and the Amplex
UltraRed assay was used for LOX activity measurements
(33). Activity was completely inhibited by b-APN.We then
detected oxidation of TE by LOXL2 but not of laminin (Fig.
6A). MS indeed confirmed the presence of allysines in
LOXL2-treated TE (Fig. 6B), whereas neither allysine nor
cross-link were detected in recombinant TE alone. The oxi-
dation of lysine residues resulted in cross-linking of TE, as
suggested by the formation of an insoluble, gel-like, elastic
material formed at the bottom of the reaction tube during a
24-h incubation (Supplemental Video S1). Optimal cross-
linking conditions were determined by varying the tem-
perature and enzyme:substrate ratio, and it was found that
50°C and an enzyme:substrate ratio of 1:500 resulted in the
highest yields of 656 6% (n=4) cTEbasedon the amount of
TE used for in vitro cross-linking. cTE was further analyzed
for the formationofcovalent cross-linksbyMS.Thepresence
of intramolecularly cross-linked peptides was identified by
detection of dehydrolysinonorleucine (Fig. 6C). In addition,
the tetrafunctional cross-link desmosine was also detected
after total hydrolysis of cTE in 6 M HCl and subsequent
LC–MS/MS analysis on an ion trap instrument (Fig. 6D). In
agreement with these data, comparison of the results of
aminoacidanalysisofTEandcTErevealed thatup to14%of
all lysine residues were either modified to allysine residues
or involved in cross-linking in cTE (Supplemental Fig. S3).
Hence, compared with aortic elastin, in which about 90%
of the lysine residues are cross-linked, lysine residues in
cTEwere about 6 times lessmodified.Overall, investigation
of peptides in the proteolytic digests of cTE by MS/MS
allowed the identification and assignment of 6 free ally-
sine residues and 3 intrapeptidal bifunctional dehy-
drolysinonorleucine cross-links (Fig. 6E).
Characterization of cTE
Scanning EM of cTE revealed a similar appearance when
compared with human aortic elastin (Fig. 7A, B). We then
investigated the biophysical properties of cTE. The Tg of
cTEwas determined to be 160°C,whereas theTg of bovine
aortic elastin was found to be 180°C (Supplemental Fig.
S4A). The swelling properties of bovine aortic elastin and
cTE were also determined and compared: 1 mg of bovine
elastin absorbed1.760.3mgand1.360.1mgofwater at 4
and 37°C, respectively. In contrast, 1 mg of cTE took up
35.1 6 2.8 mg and 39.7 6 8.4 mg of water at 4 and 37°C,
respectively (Supplemental Fig. S4B). We then character-
ized the impact of LOXL2-mediated cross-linking of TE on
stiffness and resistance to proteolytic digestion. The re-
ducedmodulus, ameasure of stiffness,wasdeterminedby
AFM for rehydrated cTE and compared with that of hu-
man aortic elastin (Fig. 7C). Whereas the human mature
elastin had a reduced modulus of 144.2 6 10.8 kPa, a re-
duced modulus of 193.1 6 13.9 kPa was determined for
cTE.With regard to proteolytic susceptibility, both bovine
aortic elastin and cTE samples were readily degraded by
porcine PE and human CG without any remaining in-
soluble residue, whereas differences were observed in the
susceptibility to cleavage by trypsin. Whereas mature
elastin was completely resistant to cleavage by trypsin,
cTE was found to be partly cleaved. In total, 47% of
the insoluble cTE pellet was still present after digestion
with trypsin for 24 h, indicating that LOXL2-mediated
cross-linking protected TE from proteolytic digestion. In
Figure 4. Comparison of SAXS and EM data for FL-LOXL2
with the crystal structure of LOXL2 N455Q lacking SRCR
domains 1 and 2. A) Crystal structure directly superimposed on
the EM model (mesh). B, C) The 2 rigid-body models that best
ﬁt the FL-LOXL2 EM reconstruction (B) and MONSA-SAXS
model (C). SRCR domains are numbered and colored from
blue at the N terminus to red at the C terminus. The catalytic
domain and SRCR domain 4 from the crystal structure were
treated as a rigid body, whereas SRCR domains 1–3 had
ﬂexible linkers (represented as dashed lines). The catalytic
domain is shown in red and SRCR region in blue (C). Scale
bars, 5 nm.
CROSS-LINKING OF TROPOELASTIN BY LOXL2 5475
Downloaded from www.fasebj.org by Koebenhavns Koebenhavns (130.225.178.2) on September 11, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 5468-5481.
contrast, with non–cross-linked substrate, no TE could be
detected10minafter additionof trypsin.Thedifferences in
the proteolytic digests are shown as peptide profiles ac-
quired usingHPLC-MS in Fig. 7D. Themass spectra of the
released peptides from cTE revealed that most were
smaller than 2 kDa, whereas larger breakdown products
were observed in the TE digest.
Vascular expression of LOXL2 and elastin
To address the in vivo relevance of TE cross-linking by
LOXL2,we investigated its distribution in the vasculature.
We have already demonstrated the expression of LOXL2
in endothelial cells of growing capillaries during devel-
opment and postischemic revascularization of the hind
limb (9). We here detected LOXL2 in vessels of the tibialis
anterior muscle, both in capillaries and arterioles where it
displayed a comparatively strong staining in the media
(Fig. 8A). LOXL2 was also detected in the aorta, both in
smoothmuscle cells of themediaand in endothelial cells of
the intima, with a similar pattern as LOX (Fig. 8B). Fur-
thermore, both proteins were detected in aorta lysates by
Western blot analysis (Fig. 8C). Sequential extraction of
proteins by Triton X-100 followed by SDS solubilization
and reduction of the insoluble material allowed detec-
tion of LOX andLOXL2 in the same fraction as fibronectin
(Fig. 8C).
DISCUSSION
We here provide nanoscale structural data describing the
organization of a mammalian member of the LOX family
using recombinant human FL-LOXL2 purified from the
secretion medium of eukaryotic cells. We show that
LOXL2 is organized as a stalk composed of SRCR14, ex-
posing the catalytic domain at its tip.We observed similar
structures using the independent approaches of SAXS and
EM. Our data suggest that SRCR domains 1 and 2 are
located away from the catalytic domain, supporting the
notion that LOXL2 processing is not associated with en-
zyme activation, as recently proposed in Lo´pez-Jime´nez
et al. (4). Sucha structuralorganizationnevertheless fits the
recently described processing of LOXL2 between SRCR
domains 2 and 3. Indeed, the string-of-pearls organization
of the SRCR domains and the flexibility of the 23-residue
linker between SRCR2 and SRCR3 supports the exposure
of a cleavage site in this linker and thus the release of
the N-terminal domains 1 and 2 upon cleavage. Cleavage
of LOX and LOXL1 participates in enzyme activation
through processing by BMP-1 (29–31). We show here that
this protease is not able to process LOXL2. On the other
hand, LOXL2 processing at Arg-Phe-Arg-Lys (RFKR) by a
serine protease was recently described in Lo´pez-Jime´nez
et al. (4), in agreement with the inhibition of LOXL2 pro-
cessing by serine protease inhibitors as reported here. Our
data also fit with the crystal structure of a truncated and
inactive LOXL2 enzyme that was recently reported in
Zhang et al. (24). In addition, comparing both structures
suggests that a conformational change could occur upon
cleavage of the 2 N-terminal domains, bringing SRCR
domain 3 closer to the catalytic site. Such a change would
not be associated with enzyme activation but could mod-
ulate substrate binding, as suggested for collagen IV (4).
The association of LOXL2 with ELN as a susceptibility
gene for glaucoma was already proposed in Urban et al.
(34), but no functional interaction between these proteins
was demonstrated in this study. More recently, the iden-
tification of LOXL2 mutations in patients suffering from
middermal elastolysis directly raised the possibility that
LOXL2 could participate in elastin cross-linking (14). We
showhere the direct binding of LOXL2 toTEusing surface
plasmon resonance, and we could detect lysine oxidation
by recombinant LOXL2. Oxidation of soluble TE by
LOXL2 had already been suggested in Xu et al. (35). Fur-
thermore, deleting SRCR domains 1–3 had no impact on
such activity, which further supports that FL-LOXL2 does
not require activation and is fully active on this substrate.
Therewas, however, no experimental data demonstrating
Figure 5. Direct interaction between LOXL2 and TE. A) Binding between immobilized LOXL2 was analyzed with TE as analyte
using surface plasmon resonance. B) Binding constants were determined using steady-state binding analysis, which gives a
dissociation constant of 146 6 16 nM (n = 4).
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the cross-linking of TE byLOXL2 [reviewed byMoon et al.
(2)]. We show here for the first time that TE is cross-linked
into an insoluble, gel-like material under the influence of
LOXL2 in vitro. Themuch lower rate of lysinemodification
in cTE compared with mature elastin generated in vivo
could result from either the in vitro experimental condi-
tions or the lack of elastin-associated proteins such as
fibulins. Alternatively, the limited cross-linking of TE by
LOXL2 detected at 37°C could indicate that this enzyme
could only be a minor player in the armament of elastin
cross-linking enzymes. Physicochemical characterization
of cTE in comparison with isolated aortic elastin revealed
that cTE shares similarities but also differences with
mature elastin. The cross-links dehydrolysinonorleucine
(DLNL), desmosine, and isodesmosinewere found in cTE;
however, they were at lower abundance compared with
Figure 6. LOXL2-mediated modiﬁcation of lysines results in cross-linking of TE. A) Recombinant LOXL2 activity was measured
using the Amplex UltraRed assay using either cadaverine (blue) or TE (yellow) as a substrate. No release of H2O2 was detected in
the presence of 500 mM b-APN (gray) or when using laminin (green) as a substrate. B, C) Annotated product ion spectra of an
allysine (Lya)-containing peptide with m/z 849.9803 (z = 2) (B) as well as an intramolecularly cross-linked peptide (m/z 509.7868;
z = 2) possessing a dehydrolysinonorleucine (DLNL) (C). Both peptides were identiﬁed in a digest of cTE. The amino acid
sequences are displayed in the upper-right corners of the spectra. Corresponding b-ions and a-ions are highlighted in blue, y-ions
are shown in red, and internal fragments are shown in green; product ions denoted with ° indicate loss of water. D) Tandem mass
spectrum of free desmosine (M1 526.29) detected in a TE sample cross-linked by LOXL2 after total hydrolysis (bottom). The
fragment pattern shows clear conformity with a desmosine standard (top) and veriﬁes the presence of desmosine in the sample.
E) Domain structure of human TE (isoform 2) indicating the identiﬁed allysines and cross-linking sites within the sequence. Lys
residues are shown as ﬁlled circles within Lys-Ala (KA) and Lys-Pro (KP) domains highlighted in dark and light blue, respectively.
The domain numbering shown is based on exon assignment, and all domains are displayed in appropriate size corresponding to
their relative length. In total, we identiﬁed 3 intramolecular bifunctional cross-links and 6 allysine residues.
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mature elastin, indicating that cTE is less or differently
cross-linked. cTE nevertheless clearly exhibits elastic pro-
perties and a reduced elasticmodulus of the sameorder of
magnitude as for elastin. However, the slightly higher
stiffness and lower Tg of cTE indicate differences in the
organization of the 2 materials. With respect to suscepti-
bility toward enzymatic cleavage, cTE exhibits significant
resistance to trypsin digestion,whereas non-cTE is readily
hydrolyzed. Because there are very few arginine residues
in mature elastin and most of the lysine residues are in-
volved in covalent cross-linking inmature elastin (36), it is
virtually completely resistant to trypsin. cTE was, how-
ever, partly cleaved by trypsin at longer incubation times,
suggesting that not all lysine residues present in cTE are
fully involved in cross-linking. It is worthmentioning that
the cTE generated by LOXL2 exhibited a much higher re-
sistance against trypsin in comparisonwith the elastin-like
biomaterial formed after exposure of TE to an amine oxi-
dase from Aspergillus nidulans, which was fully degraded
by trypsin after 8 h in similar experimental conditions (28).
Modulating the cross-linking conditions such as temper-
ature, TE:LOXL2 ratio, and incubation time could further
enable tuning of the cTE characteristics, including pro-
teolytic resistance and mechanical properties.
Whereas inactivation of both LOX and LOXL1 genes
affects elastin cross-linking, these effects areonlypartial, as
measured by the amount of desmosine in the lungs of
LOX2/2 mice (6) and of LOXL12/2 mice (7). These data
suggest that elastin cross-linking does not result from the
activity of a single member of the LOX family. Elastin
synthesis is a multistep process comprising coacervation
of TE, microfibrillar deposition, and cross-linking. The
order of these events is not completely understood, and
it has been proposed that cross-linking could precede
deposition (37). Whereas coacervation of TE has been
extensively studied in vitro over the past 30 yr (38), in-
vestigation of cross-linkinghasbeen limitedbecause of the
lackor limitedavailabilityofLOXenzymes. Invitro studies
have demonstrated that self-assembly results from inter-
actions between the hydrophobic domains of TE and that
Figure 7. LOXL2-mediated cross-linking of TE results in formation of an insoluble elastin-like material. A, B) Scanning electron
micrographs of isolated aortic elastin (AE) (A) and cTE (B). C) Local micromechanical stiffness was measured by AFM
indentation of aortic elastin and cTE. The distribution of reduced modulus values (main panel) was signiﬁcantly shifted to the
right for cTE (red) when compared with aortic elastin (blue). Analysis of mean reduced modulus values from 2 replicates (inset
panel) showed that cTE (red; 193.1 6 13.9 kPa) exhibited a signiﬁcantly increased reduced modulus when compared with aortic
elastin (blue; 144.2 6 10.8 kPa). ***P , 0.0005. D) Total ion current intensity chromatograms obtained by nano–HPLC-MS runs
of the 24-h tryptic digests of cTE (red) vs. unmodiﬁed TE in solution (black).
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polymerization results from cross-linking of lysines
present in the hydrophilic domains. Cross-linking
provides both structural restrictions and stability to
elastic fibers, together with insolubility and protease
resistance (39). Stabilization of intermediate states
through cross-linking could also participate in tuning
elastin organization. Indeed, the importance of lability
of the hydrophilic cross-linking domains for coacerva-
tion was recently demonstrated in Reichheld et al. (40),
possibly by preventing inappropriate aggregation.
Such a function could be achieved by the intradomain
cross-links generated by LOXL2 that we have detected.
Indeed, analysis of cross-links in native elastin demon-
strated the presence of many intramolecular cross-links
resulting in an unordered network of TE molecules (41).
This hypothesis thus raises the possibility that LOXL2
participates in some steps of elastogenesis together with
other LOXs. The recent identification of patients suffering
from middermal elastolysis also supports the direct in-
volvement of LOXL2 in the stability and maintenance of
elastin (14).
LOX inactivation results in perinatal aorta rupture,
with 61% inhibition of elastin cross-links in the aorta,
whereas LOXL1 has no effect on aorta development,
suggesting regulation of elastogenesis and cross-linking
in a tissue-specific manner. An interesting hypothesis
could be that LOXL2 participates in elastin cross-linking
in the vascular wall. Inactivation of the LOXL2 gene is
lethal in 50% of the newborn mice as a result of con-
genital heart defects and results in vascular defects in
the surviving animals, but no substrate has been iden-
tified to be involved in this phenotype up to now (42).
We could detect the localization of LOXL2 in the vas-
cular wall of arterioles and the aorta, with a similar
distribution as already described for LOX in Liu et al.
(7). Expression of LOXL2 in the wall of small arteries
had already been described in Csiszar (43). More re-
cently, LOXL2 was detected in retina arterioles, with
increased expression in growing microaneurysms (44).
Finally, in addition to raising the possibility that
LOXL2 is involved in elastin cross-linking in vivo,
our study allowed characterization of LOXL2 as a bio-
mimetic tool that should be considered for the gen-
eration of elastin as a biomaterial. Indeed, whereas
chemical cross-linking is often associated with toxicity
that limits its use for cell-based therapies in tissue en-
gineering, a biomimetic approach based on LOXL2-
mediated cross-linking could improve the mechanical
properties of elastin-based biomaterials without af-
fecting cell survival.
Figure 8. LOXL2 is expressed in the vascular wall. A) LOXL2 was detected in cryostat sections of mouse tibialis anterior. Whereas
type IV collagen (Col IV) was detected in the basement membrane of both blood vessels and muscle ﬁbers, LOXL2 was restricted
to blood vessels (arrows), with a very high expression in arterioles (arrowheads). Scale bars, 50 mm. B) LOX and LOXL2 were
detected in the intima (arrows) and media of mouse aorta cryosection by immunoﬂuorescence, together with elastin
autoﬂuorescence (green). Scale bars, 50 mm. C) Aorta were frozen and extracted with Triton X-100 followed by SDS extraction of
the insoluble fraction before separation by SDS-PAGE. LOX and LOXL2 were both detected in the Triton X-100–resistant ECM
fraction together with ﬁbronectin.
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